Decreased interleukin-1β and elastase in the gingival crevicular fluid of individuals undergoing anti-inflammatory treatment for rheumatoid arthritis

Journal of Periodontology

Volumn 78, Issue 8, 2007, Pages 1612-1619

  Miranda, Leticia A ^a,b,c   Islabão, Alexandre G ^c   Fischer, Ricardo G ^d   Figueredo, Carlos M S ^d   Oppermann, Rui V ^e   Gustafsson, Ande ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Elastase; Gingival crevicular fluid; Interleukin 1 beta; Interleukin 18; Periodontitis; Rheumatoid arthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 18; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PANCREATIC ELASTASE; PARACETAMOL; PREDNISONE;

ARTICLE; CASE CONTROL STUDY; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ENZYMOLOGY; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; RHEUMATOID ARTHRITIS; SMOKING; TOOTH PLAQUE;

ACETAMINOPHEN; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PANCREATIC ELASTASE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; PREDNISONE; SMOKING;

EID: 34548064270     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060520     Document Type: Article

References (48)

1. Lamster I, Sonis S, Hannigan A, Kolodkin A. An association between Crohn's disease, periodontal disease and enhanced neutrophil function. J Periodontol 1978;49:475-479.
2. Kupari M, Teerenhovi L. Plasma exchanges in the treatment of rapidly progressive glomerulonephritis associated with chronic dental infection. Acta Med Scand 1981;210:511-514.
3. Engel LD, Pasquinelli KL, Leone SA, Moncla BJ, Nelson KD, Rabin K. Abnormal lymphocyte profiles and leukotriene B4 status in a patient with Crohn's disease and severe periodontitis. J Periodontol 1988; 59:841-847.
4. Flemmig TF, Shanahan F, Miyasaki KT. Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. J Clin Periodontol 1991; 18:690-697.
5. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
6. Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 2005;76:229-233.
7. Helminen-Pakkala E, Laine V. The relationship between periodontal findings and articular involvement in a group of subjects suffering from rheumatoid arthritis. Proc Finn Dent Soc 1973;69:52-55.
8. Sjostrom L, Laurell L, Hugoson A, Hakansson JP. Periodontal conditions in adults with rheumatoid arthritis. Community Dent Oral Epidemiol 1989;17:234-236.
9. Tolo K, Jorkjend L. Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis. J Clin Periodontol 1990;17:288-291.
10. Arneberg P, Bjertness E, Storhaug K, Glennas A, Bjerkhoel F. Remaining teeth, oral dryness and dental health habits in middle-aged Norwegian rheumatoid arthritis patients. Community Dent Oral Epidemiol 1992;20:292-296.
11. YavuzyiImaz E, Yamalik N, Calguner M, Ersoy F, Baykara M, Yeniay I. Clinical and immunological characteristics of patients with rheumatoid arthritis and periodontal disease. J Nihon Univ Sch Dent 1992; 34:89-95.
12. Kasser UR, Gleissner C, Dehne F, IvUchel A, Willershausen-Zonnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997;40:2248-2251.
13. Gleissner C, Willershausen B, Kaesser U, Bolten WW. The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur J Med Res 1998;3: 387-392.
14. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol 2000;27: 267-272.
15. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol 2001;72:779-787.
16. Miranda LA, Fischer RG, Stajnbok FR, Figueredo CMS, Gustafsson A. Periodontal conditions in juvenile idiopathic arthritis patients. J Clin Periodontol 2003;30: 969-974.
17. Miranda LA, Fischer RG, Sztajnbok FR, Johansson A, Figueredo CM, Gustafsson A. Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J Periodontol 2005;76:75-82.
18. Miranda LA, Braga F, Fischer RG, Sztajnbok FR, Figueredo CM, Gustafsson A. Changes in periodontal and rheurnatological conditions after 2 years in patients with juvenile idiopathic arthritis. J Periodontol 2006;77:1695-1700.
19. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-346.
20. 2 in gingival crevicular fluid of rheumatoid arthritis patients with periodontal disease. J Clin Periodontol 2006;33:605-611.
21. Figueredo, CM, Ribeiro MS, Fischer RG, Gustafsson A. Increased interleukin- 1 beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999;70:1457-1463.
22. Ainamo J, Bay 1. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-235.
23. Figueredo, CMS, Gustafsson A. Protease activity in gingival crevicular fluid. J Clin Periodontol 1998;25: 306-310.
24. Barrera P, Boerbooms AM, van de Putte LB, van der Meer JW. Effects of antirheumatic agents on cytokines. Semin Arthritis Rheum 1996;25:234-253.
25. Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998;47:S78-S87.
26. Bondeson J. Effects of tenidap on intracellular signal transduction and the induction of proinflammatory cytokines: A review. Gen Pharmacol 1996;27:943-956.
27. Lee SW, Tsou AP, Chan H, et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci USA 1988;85:1204-1208.
28. Loetscher P, Dewald B, Baggiolini M, Seitz M. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine 1994;6:162-170.
29. Boss B, Neeck G, Engelhardt B, Riedel W. Influence of corticosteroids on neutrophils, lymphocytes, their subsets, and T-cell activity markers in patients with active rheumatoid arthritis, compared to healthy controls. Ann N Y Acad Sci 1999;876:198-200.
30. Conn DL. Resolved: Low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis. Arthritis Rheum 2001;45:462-467.
31. Neurath MF, Hildner K, Becker C, iet al. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): A mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol 1999; 115:42-55.
32. Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002;4: 266-273.
33. Youssef P, Roberts-Thomson P, Ahern M, Smith M. Pulse methylprednisolone in rheumatoid arthritis: Effects on peripheral blood and synovial fluid neutrophil surface phenotype. J Rheumatol 1995;22:2065-2071.
34. Nowak D, Lewandowicz J, Dbkowska B, Marczak J. Combination of methotrexate and prednisone decreases circulating concentrations of interleukin 1 beta and interleukin 6 in patients with rheumatoid arthritis. Poor correlation of cytokine suppression with clinical improvement. Int J Immunopathol Pharmacol 1999; 12:13-21.
35. Thomas R, Carrol GJ. Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1993;36:1244-1252.
36. Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF. Interleukin 1 b, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res 2003;38:247-254.
37. Altomonte L, Zoli A, Mirone L, Scolieri P, Magaro M. Serum levels of interleukin- 1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity. Clin Rheumatol 1992; 11: 202-205.
38. Lettesjo H, Nordstrom E, Strom H, et al. Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol 1998;48:286-292.
39. Havemose-Poulsen A, Sorensen LK, Stoltze K, Bendtzen K, Holmstrup P. Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2005;76:2276-2285.
40. Figueredo CM, Gustafsson A. Activity and inhibition of elastase in GCF. J Clin Periodontol 1998;25:531-535.
41. Momohara S, Kashiwazaki S, Inoue K, Saito S, Nakagawa T. Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis. Clin Rheumatol 1997; 16:133-140.
42. Bokarewa M, Hultgren O. Is interleukin-18 useful for monitoring rheumatoid arthritis? Scand J Rheumatol 2005;34:433-436.
43. Rooney T, Murphy E, Benito M, et al. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis 2004;63:1393-1398.
44. Bozkurt FY, Berker E, Akkus S, Bulut S. Relationship between interleukin-6 levels in gingival crevicular fluid and periodontal status in patients with rheumatoid arthritis and adult periodontitis. J Periodontol 2000; 71:1756-1760.
45. Bozkurt FY, Yetkin Ay Z, Berker E, Tepe E, Akkus S. Anti-inflammatory cytokines in gingival crevicular fluid in patients with periodontitis and rheumatoid arthritis: A preliminary report. Cytokine 2006;35:180-185.
46. Reinhardt RA, Masada MP, Payne JB, Allison AC, DuBois LM. Gingival fluid IL-1 beta and IL-6 levels in menopause. J Clin Periodontol 1994;21:22-25.
47. Salvi GE, Yalda B, Collins JG, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-135.
48. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ, et al. Gingival crevicular fluid levels of interleukin- 1 beta and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontol 2004;75: 1203-1208.